Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Nov 20;138(22):3010-3012.
doi: 10.1097/CM9.0000000000003666. Epub 2025 Jul 25.

Outcomes of patients with HIV-associated Burkitt lymphoma treated with R-DA-EPOCH regimen: A single-center experience in Shanghai, China

Yueming Shao  1 , Zhenyan Wang, Wei Song, Yang Tang, Tangkai Qi, Li Liu, Jun Chen, Yinzhong Shen, Renfang Zhang
Affiliations

Outcomes of patients with HIV-associated Burkitt lymphoma treated with R-DA-EPOCH regimen: A single-center experience in Shanghai, China

Yueming Shao et al. Chin Med J (Engl). .
No abstract available

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Figure 1
Figure 1
Comparison of Kaplan–Meier estimates of the overall survival and progression-free survival rates among patients in each NCCN risk (A and B) and BL-IPI risk (C and D) group. BL-IPI: Burkitt lymphoma International Prognostic Index; NCCN: National Comprehensive Cancer Network.
See this image and copyright information in PMC

References

    1. Sun JJ Liu L Wang JR Shen YZ Qi TK Wang ZY, et al. Clinical outcomes of people living with human immunodeficiency virus (HIV) with diffuse large B-cell lymphoma (DLBCL) in Shanghai, China. Chin Med J 2020;133:2796–2802. doi: 10.1097/cm9.0000000000001180. - PMC - PubMed
    1. Olszewski AJ Jakobsen LH Collins GP Cwynarski K Bachanova V Blum KA, et al. Burkitt lymphoma International Prognostic Index. J Clin Oncol 2021;39:1129–1138. doi: 10.1200/jco.20.03288. - PMC - PubMed
    1. Zhang R, Sun J. A case report of acquired immunodeficiency syndrome (AIDS)-related refractory Burkitt lymphoma got complete remission by multidisciplinary and multi-target combined therapy. Transl Cancer Res 2022;11:1806–1812. doi: 10.21037/tcr-22-1375. - PMC - PubMed
    1. Shen Y Zhang R Liu L Shen Y Song W Qi T, et al. Clinical and prognostic analysis of 78 patients with human immuno-deficiency virus associated non-Hodgkin’s lymphoma in Chinese population. Infect Agent Cancer 2017;12:7. doi: 10.1186/s13027-017-0120-2. - PMC - PubMed
    1. Cheng Q, Wang J, Lv C, Xu J. Successful management of a patient with refractory primary central nervous system lymphoma by zanubrutinib. Onco Targets Ther 2021;14:3367–3372. doi: 10.2147/OTT.S309408. - PMC - PubMed

LinkOut - more resources